ScreenIn3D, a partner of AMSBIO, has been awarded the ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019.

Onconova and Inceptua Medicines Access have announced that they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Hypha Discovery has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide.

Intellegens and Optibrium™ have announced joint success in the Open Source Malaria (OSM) global initiative aimed at identifying the best predictive models for antimalarial compounds.

Metrion and LifeArc have announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement.

LUNAC Therapeutics (LUNAC) has been awarded £3.14M under Innovate UK’s Biomedical Catalyst programme, to help develop a next-generation anticoagulant.

Prokarium has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with a bivalent vaccine against enteric fever.

The global pharmaceutical company and service partner Inceptua and Bendalis have announced the signing of an exclusive clinical trial supply agreement for oncology generics.

Porvair Sciences has developed a new range of filters for pipette tips for a leading separation science supplier.

Uniqsis has installed a 4-channel FlowSyn™ flow chemistry system in the Riley Research Group Laboratories at the University of Pretoria.